RNA amplification is a series of molecular manipulations designed to amplify genetic signals from small quantities of starting materials (including single cells and homogeneous populations of individual cell types) for microarray analysis and other downstream genetic methodologies. A novel methodology named terminal continuation (TC) RNA amplification has been developed in this laboratory to amplify RNA from minute amounts of starting material. Briefly, an RNA synthesis promoter is attached to the 3′ and/or 5′ region of cDNA utilizing the TC mechanism. The orientation of amplified RNAs is "antisense" or a novel "sense" orientation. TC RNA amplification is utilized for many downstream applications, including gene expression profiling, microarray analysis, and cDNA library/subtraction library construction. Input sources of RNA can originate from a myriad of in vivo and in vitro tissue sources. Moreover, a variety of fixations can be employed, and tissues can be processed for histochemistry or immunocytochemistry prior to microdissection for TC RNA amplification, allowing for tremendous cell type and tissue specificity of downstream genetic applications.
RNases. Because they play an important role in nucleic acid metabolism, RNases are found in virtually every cell type [7] . RNases degrade RNA species through endonuclease and exonuclease activity. RNases are quite stable and retain their activity over a broad pH range [7, 8] . Thus, RNase-free precautions need to be taken prior to and during all RNA amplification procedures. All biological samples require prompt handling, either through rapid RNA extraction, flash freezing, or fixation to minimize the degradation of intracellular RNAs by RNases.
Significant discourse centers on devising optimal methods to prepare brain tissues for downstream genetic analyses. Consensus on which protocol should be utilized has not yet been achieved. RNAs have been mined from tissue samples using cross-linking fixatives, including 10% neutral buffered formalin and 4% paraformaldehyde, as well as precipitating fixatives, such as 70% ethanol buffered with 150 mM sodium chloride [3, 4, 9, 10] . A useful method for assessing RNA quality in tissue sections prior to performing expression profiling studies is acridine orange (AO) histofluorescence. AO is a fluorescent dye that intercalates selectively into nucleic acids and has been used to detect RNA and DNA in brain tissues [11] [12] [13] [14] . AO can be employed in combination with immunocytochemistry to identify cytoplasmic RNAs and specific antigens of interest and is compatible with confocal microscopy [15, 16] . In brain tissue sections, AO-positive neurons are in contrast to the pale background of white matter tracts that lack abundant nucleic acids. Nonneuronal cells tend to have less AO histofluorescence than neurons and brain tumor cells [17] . Importantly, individual RNA species (e.g., mRNA, rRNA, and tRNA) cannot be delineated by AO histofluorescence. Rather, this method provides a diagnostic test employed on adjacent tissue sections to ensure the likelihood that an individual case has abundant RNA prior to performing expensive expression profiling studies. A more thorough examination of RNA quality can be obtained via bioanalysis (e.g., 2100 Bioanalyzer, Agilent Technologies), which utilizes capillary gel electrophoresis to detect RNA quality and quantitate relative abundance [18] [19] [20] . Bioanalysis displays the analytical assessment of RNAs in an electropherogram or digital gel format, with relatively high sensitivity.
Microarray analysis has emerged as a useful and relatively cost-effective tool to assess transcript levels in a myriad of systems and paradigms. A disadvantage to these highthroughput technologies is a requirement for significant amounts of high-quality input sources of RNA for increased sensitivity and reproducibility. Whole organism and regional studies can generate significant input amounts of RNA species without any amplification procedures [21, 22] . Unfortunately, the quantity of RNA harvested from a single cell, estimated to be approximately 0.1-1.0 picograms, is not sufficient for standard RNA extraction procedures [23] [24] [25] . As a result, molecular-based methods have been developed to increase the amount of input RNA for downstream genetic analyses, including exponential PCR-based analyses and linear RNA amplification procedures. This protocol describes one RNA amplification procedure, terminal continuation (TC) RNA amplification.
A new procedure was developed in our laboratory, TC RNA amplification ( Fig. 10.1) [18, 19, 26] . TC RNA amplification of genetic signals includes synthesizing the first-strand cDNA complementary to the mRNA template, subsequently generating second-strand cDNA complementary to the first-strand cDNA, and finally in vitro transcription (IVT) using the double-stranded cDNA as a template [18, 19, 26] . First-strand cDNA synthesis complementary to the template mRNA entails the use of two oligonucleotide primers, a first-strand poly d(T) primer and a TC primer. The poly d(T) primer is similar to conventional primers that exploit the poly(A) sequence present on most mRNAs. The TC primer contains a span of three cytidine triphosphates (CTPs) or guanosine triphosphates (GTPs) at the 3′ terminus [18] . Adenosine triphosphates (ATPs) or thymidine triphosphates (TTPs) do not perform well as constituents of the TC primer [20] . In this configuration, second-strand cDNA synthesis can be initiated by annealing a second oligonucleotide primer complementary to the attached oligonucleotide [18] , and can be performed with robust DNA polymerases, such as Taq polymerase. One round of amplification is sufficient for downstream genetic analyses [18, 26] . Additionally, TC RNA transcription can be performed using a promoter sequence (e.g., T7, T3, or SP6) attached to either the 3′ or 5′ oligonucleotide primers. Therefore, transcript orientation can be in an antisense orientation (similar to conventional amplified antisense RNA methods) when the bacteriophage promoter sequence is placed on the first-strand poly d(T) primer, or in a sense orientation when the promoter sequence is attached to the TC primer, depending on the design of the experimental paradigm ( Fig. 10.1) [19, 27] . Regional and single cell gene expression studies within the brains of animal models and human postmortem brain tissues have been performed via microarray analysis coupled with TC RNA amplification ( Fig. 10.2) 
Materials
The methodology described here is a step-by-step protocol for TC RNA amplification as described by Che and Ginsberg [18, 19] . For clarity, the protocol begins at the point where cells are captured via laser-capture microdissection (LCM) or a microaspiration strategy and follows through IVT using biotinylated, fluorescent, or radioactive methods to label the TC RNA amplified products (see Notes 1 and 2 ).
Isolation of RNA

1.
Trizol reagent (Invitrogen, Carlsbad, CA), stored at 4 °C. 12 μL of 18.2 MΩ RNase-free water.
2 μL of 1,000 U/μL T7 RNA polymerase (Epicentre, Madison, WI).
IVT for TC RNA Amplification: Radioactive Probe Labeling
1.
Freshly prepared (on wet ice) IVT master mix, comprising (for each double-stranded cDNA sample) 2 μL of 10 × RNA amplification buffer (Ambion).
1 μL of 0.1 M DTT (Invitrogen).
2 μL of 3 × 2.5 mM rATP, rCTP, and rGTP (Invitrogen).
2 μL of 100 μM UTP (Invitrogen).
μL of 20 U/μL Superase-in RNase inhibitor (Ambion).
2. 20 mCi/mL 33 P-UTP (GE Healthcare, Piscataway, NJ).
3.
1,000 U/μL T7 RNA polymerase (Epicentre, Madison, WI).
Methods
Isolation of RNA
1.
Add 250 μL of Trizol reagent to the 500 μL thin-wall PCR tube that will receive the microdissected regions or cells, acquired via LCM, and keep on wet ice.
2.
Invert the tube so that the Trizol reagent bathes the microdissected material, and keep on wet ice (samples can be stored at −80 °C at this juncture for future use).
3.
Add 50 μL of phenol:chloroform:isoamyl alcohol, vortex vigorously for 15 s and centrifuge at 12,000 g for 15 min at 4 °C.
4.
Collect the clear upper aqueous phase, containing RNA, by aspirating with a pipette.
5.
Add 125 μL of 100% (v/v) 2-propanol and 5 μL of linear acrylamide to precipitate the RNA from the aqueous phase (store at −80 °C to precipitate RNA if desired).
6.
Vortex vigorously for 15 s and centrifuge at 12,000 g for 15 min at 4 °C.
7.
Decant the supernatant, by inverting the tube, being careful not to dislodge the pellet.
8.
Add 250 μL of 75% (v/v) ethanol to wash RNA pellet. Vortex vigorously for 15 s and centrifuge at 7,500 g for 5 min at 4 °C.
9.
10.
Air dry the sample by inverting the tube for 5 min in a fume hood (see Note 5).
11.
Resuspend the pellet in 5 μL of 18.2 MΩ RNase-free water.
First-Strand cDNA Synthesis
1. Add 1 μL of first-strand synthesis primer (Table 10 .1) to a 5 μL RNA sample. Pulse centrifuge for 10 s.
2.
Heat the mixture for 2 min at 75 °C. Pulse centrifuge for 10 s and place on ice.
3.
Prepare the RT master mix (on wet ice; see Note 2).
4.
Warm the RT master mix (without primers or Superscript III) for 2 min at 50 °C.
5.
Heat denature an aliquot (1 μL for each RNA sample) of 10 ng/μL TC primer (Table  10 .1) for 2 min at 70 °C, place on ice for several min and add to the RT master mix (see Note 6).
6.
Add an aliquot of Superscript III (1 μL for each RNA sample) to the RT master mix (see Note 7) . The RT master mix should constitute 14 μL per RT reaction.
7.
Add the RT master mix to the 6 μL of sample, pipette vigorously, and centrifuge briefly. Incubate the mixture for 60 min at 50 °C.
8.
Inactivate the Superscript III by heating the reaction mixture at 65 °C for 15 min.
9.
Centrifuge briefly and cool immediately on wet ice. Samples can be stored at −20 °C for a short time, or at −80 °C for the long term.
5 Do not air dry RNA pellets longer than 5 min, as the pellets become difficult to resuspend. 6 Each RNA sample to which the RT master mix is added receives 1 μL of TC RNA primer; therefore, if there are 8 RNA samples, the RT master mix must be sufficient for ten RNA samples and 10 μL of the TC primer must be added to the RT master mix prior to adding it to the RNA samples. 7 When removing aliquots of Superscript III from the tube, be extremely careful to not contaminate the vial of enzyme with primers or RNA samples. Representative array platforms illustrating utility of RNA amplification procedures for single cell and population cell analysis. (A) Spotted cDNA array platform using RNA amplified from individual hippocampal CA1 pyramidal neurons from normal control brains and from neurofibrillary tangle (NFT) bearing CA1 neurons from Alzheimer's disease (AD) patients.
(B) Dendrogram demonstrating relative expression levels of representative genes in CA1 and CA3 pyramidal neurons microaspirated from human hippocampus. A heatmap matrix plot illustrates relative expression levels for individual glutamate receptor transcripts in CA1 and CA3 neurons. A single asterisk indicates a significant increase in expression in CA3 neurons as compared to CA1 neurons and a double asterisk denotes a significant increase in expression in CA1 neurons as compared to CA3 neurons. Key: GRIA 1, alpha-amino-3-hydroxy-5-methyl-4-isoxa-zolepropionate receptor 1 (AMPA1); GRIA2, AMPA2, GRIA3, AMPA3, GRIA4, AMPA4; GRIK1, kainate (KA) receptor GluR5; GRIK2, KA GluR6; GRIK3, KA GluR7; GRIK4, KA receptor KA1; GRIK5, KA receptor KA2; GRIN1, N-methyl D-aspartate receptor 1 (NR1); GRIN2A, NR2A; GRIN2B, NR2B; GRIN2C, NR2C; GRIN2D, NR2D. Adapted from Ginsberg and Che 2005 [32] . (C) Single-cell array analysis of human CA1 pyramidal neurons using custom-designed cDNA arrays and TC RNA amplification. Representative arrays illustrate a wide dynamic range of hybridization signal intensities for eight human postmortem cases (numbers 1-8). The negative control (number 9) is a single CA1 pyramidal neuron from the first case (number 1) that does not have the primers necessary for TC RNA amplification. In addition, a moderate variation of gene level expression across the eight human cases is observed, indicating the utility of using postmortem human samples for normative and neuropathological investigations. GTG AAT TGT AAT ACG ACT CAC TAT AGG CGC TTT TTT TTT TTT TTT TTT  TTT TTT -5′   TC 
